Diabetic Kidney Disease, Drugs and Treatments 1

7 Feb 2025 5:30 p.m. 6:30 p.m.

Jatin Kothari Moderator

Time	Session

12 a.m. 12 a.m.	EFFICACY AND SAFETY OF FINERENONE IN PATIENTS WITH NEPHRECTOMY: A FIDELITY SUBANALYSIS WCN25-AB-662, Poster Board= FRI-228	CUMULATIVE EFFECTS OF THE ALDOSTERONE SYNTHASE INHIBITOR VICADROSTAT COMBINED WITH EMPAGLIFLOZIN ON ALBUMINURIA IN PEOPLE WITH CKD WCN25-AB-2620, Poster Board= FRI-229	THE USEFULNESS OF URINARY N-ACETYL- Β-D-GLUCOSAMINIDASE-CREATININE RATIO AS THE BIOMARKER TO DECIDE LONG-TERM USE OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR IN DIABETIC KIDNEY DISEASE WCN25-AB-1188, Poster Board= FRI-230	ROLE OF DESIDUSTAT IN ANEMIC CKD-EASTERN INDIA EXPERIENCE WCN25-AB-84, Poster Board= FRI-231	EFFECT OF INTRAVITREAL BEVACIZUMAB ON RENAL FUNCTION AND PROTEINURIA AMONG DIABETIC PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY IN NORTH INDIA WCN25-AB-120, Poster Board= FRI-232	EFFECT OF SGLT2 INHIBITORS ON KIDNEY FUNCTION IN INDIVIDUALS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE WITH MODERATE TO SEVERE ALBUMINURIA WCN25-AB-1411, Poster Board= FRI-233	THE SPECTRUM OF NONDIABETIC RENAL DISEASE IN DIABETES. WCN25-AB-1222, Poster Board= FRI-234	CLINICAL PROFILE OF NON DIABETIC KIDNEY DISEASE IN THE RENAL BIOPSIES OF DIABETES MELLITUS PATIENTS WCN25-AB-4019, Poster Board= FRI-235	MICRORNA (MIR)-299A-5P PROMOTES APOPTOSIS AND FIBROSIS IN DIABETIC KIDNEY DISEASE BY REGULATING MAP3K2ERK5 WCN25-AB-1941, Poster Board= FRI-236	A PROSPECTIVE, MULTI-CENTRIC, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFECTIVENESS OF SUPPLEMENTATION OF N-ACETYLCYSTEINE& TAURINE IN PREVENTING PROGRESSION OF CHRONIC KIDNEY DISEASE WCN25-AB-2546, Poster Board= FRI-237	ULTRASTRUCTURAL CHARECTORISTICS OF DIABETIC NEPHROPATHY AND ITS PREDICTIVE ROLE IN ASSESSING DISEASE PROGRESSION: A RETROSPECTIVE COHORT STUDY WCN25-AB-1780, Poster Board= FRI-238	ASSOCIATION OF IL-10 GENE PROMOTER POLYMORPHISMS (-592A/C; -819C/T) WITH DIABETIC NEPHROPATHY IN TYPE 2 DIABETES MELLITUS AMONG THE SOUTH INDIAN POPULATION WCN25-AB-2101, Poster Board= FRI-239	PROPORTION OF RAPID PROGRESSION OF DIABETIC NEPHROPATHY AND THE FACTORS ASSOCIATED WITH IT AMONG PATIENTS ATTENDING A TERTIARY CARE CENTRE IN SOUTH INDIA WCN25-AB-2220, Poster Board= FRI-240	FINRENONE IN DIABETIC NEPHROPATHY: REAL-WORLD EXPERIENCE FROM CENTRAL INDIA WCN25-AB-3234, Poster Board= FRI-241	BURDEN AND EXCESS RISK OF ADVERSE OUTCOMES IN PATIENTS WITH TYPE 1 DIABETES UTILIZING KDIGO CLASSIFICATION: A NATIONAL COHORT STUDY WCN25-AB-4079, Poster Board= FRI-242	UTILITY OF SERIAL MULTIPARAMETRIC MRI FOR MONITORING DISEASE PROGRESSION IN DIABETIC KIDNEY DISEASE: A PROSPECTIVE STUDY WCN25-AB-3850, Poster Board= FRI-243	PRACTICE OF DRUG DOSE ADJUSTMENT IN ADMITTED PEDIATRIC PATIENTS WITH RENAL IMPAIRMENT, ST.PAUL’S HOSPITAL MILLENIUM MEDICAL COLLEGE, ADDIS ABABA, ETHIOPIA, 2022 WCN25-AB-4194, Poster Board= FRI-244	PODOCYTE INFOLDING GLOMERULOPATHY: UNRAVELING ITS CLINICAL AND PATHOLOGICAL ASSOCIATIONS WCN25-AB-4272, Poster Board= FRI-245	UNVEILING DIABETIC FIBRILLOSIS: CLINICAL AND ULTRASTRUCTURAL CORRELATIONS IN DIABETIC NEPHROPATHY WCN25-AB-4271, Poster Board= FRI-246